Photodynamic therapy – mechanisms, photosensitizers and combinations

Luo, 2017, Chemophototherapy: an emerging treatment option for solid tumors, Adv. Sci., 4, 1600106, 10.1002/advs.201600106

Kharkwal, 2011, Photodynamic therapy for infections: clinical applications, Lasers Surg. Med., 43, 755, 10.1002/lsm.21080

Sperandio, 2013, Antimicrobial photodynamic therapy to kill Gram-negative bacteria, Recent Pat. Antiinfect. Drug Discov., 8, 108, 10.2174/1574891X113089990012

Schmitt, 2012, Drug targeting strategies for photodynamic therapy, Anticancer Agents Med. Chem., 12, 500, 10.2174/187152012800617830

Allison, 2013, Photodynamic therapy (PDT): PDT mechanisms, Clin. Endosc., 46, 24, 10.5946/ce.2013.46.1.24

Robertson, 2009, Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT, J. Photochem. Photobiol. B Biol., 96, 1, 10.1016/j.jphotobiol.2009.04.001

Castano, 2005, Mechanisms in photodynamic therapy: part two—cellular signaling, cell metabolism and modes of cell death, Photodiagn. Photodyn. Ther., 2, 1, 10.1016/S1572-1000(05)00030-X

Nowak-Stepniowska, 2013, [Photodynamic method of cancer diagnosis and therapy--mechanisms and applications], Postepy Biochem., 59, 53

Luksiene, 2003, Photodynamic therapy: mechanism of action and ways to improve the efficiency of treatment, Med. (Kaunas), 39, 1137

Juzeniene, 2007, The history of PDT in Norway, Photodiagn. Photodyn. Ther., 4, 3, 10.1016/j.pdpdt.2006.11.002

Fonseca, 2006, Triplet-state and singlet oxygen formation in fluorene-based alternating copolymers, J. Phys. Chem. B, 110, 8278, 10.1021/jp060251f

Kessel, 2010, Photodynamic therapy and cell death pathways, 35, 10.1007/978-1-60761-697-9_3

Plaetzer, 2003, The modes of cell death induced by PDT: an overview, Med. Laser Appl., 18, 7, 10.1078/1615-1615-00082

Buytaert, 2007, Molecular effectors of multiple cell death pathways initiated by photodynamic therapy, Biochim. Biophys. Acta Rev. Cancer., 1776, 86, 10.1016/j.bbcan.2007.07.001

Mehraban, 2015, Developments in PDT sensitizers for increased selectivity and singlet oxygen production, Mater. (Basel Switz.), 8, 4421, 10.3390/ma8074421

Vrouenraets, 2003, Basic principles, applications in oncology and improved selectivity of photodynamic therapy, Anticancer Res., 23, 505

Cruz, 2013, The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics, Front. Pharmacol., 4, 119, 10.3389/fphar.2013.00119

Hamblin, 1994, Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins, J. Photochem. Photobiol. B., 26, 147, 10.1016/1011-1344(94)07036-9

Castano, 2005, Mechanisms in photodynamic therapy: Part three—Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction, Photodiagn. Photodyn. Ther., 2, 91, 10.1016/S1572-1000(05)00060-8

Huang, 2008, Photodynamic therapy for treatment of solid tumors--potential and technical challenges, Technol. Cancer Res. Treat., 7, 309, 10.1177/153303460800700405

Krammer, 2001, Vascular effects of photodynamic therapy, Anticancer Res., 21, 4271

Reginato, 2014, Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects, World J. Immunol., 4, 1, 10.5411/wji.v4.i1.1

Castano, 2006, Photodynamic therapy and anti-tumour immunity, Nat. Rev. Cancer, 6, 535, 10.1038/nrc1894

Agostinis, 2011, Photodynamic therapy of cancer: an update, CA Cancer J. Clin., 61, 250, 10.3322/caac.20114

Kou, 2017, Porphyrin photosensitizers in photodynamic therapy and its applications, Oncotarget, 8, 81591, 10.18632/oncotarget.20189

Nyman, 2004, Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy, J. Photochem. Photobiol. B, 73, 1, 10.1016/j.jphotobiol.2003.10.002

Fornalski, 2006, Photodynamic therapy mechanism of action and adhibition in dermatology, Nowa Med., 4, 71

Allison, 2010, Oncologic photodynamic therapy photosensitizers: A clinical review, Photodiagn. Photodyn. Ther., 7, 61, 10.1016/j.pdpdt.2010.02.001

Taub, 2004, Photodynamic therapy in dermatology: history and horizons, J. Drugs Dermatol., 3, S8

Gold, 2011, History of photodynamic therapy, 1

Abrahamse, 2016, New photosensitizers for photodynamic therapy, Biochem. J., 473, 347, 10.1042/BJ20150942

Zhang, 2018, An updated overview on the development of new photosensitizers for anticancer photodynamic therapy, Acta Pharm. Sin. B, 8, 137, 10.1016/j.apsb.2017.09.003

Chatterjee, 2008, Nanoparticles in photodynamic therapy: an emerging paradigm, Adv. Drug Deliv. Rev., 60, 1627, 10.1016/j.addr.2008.08.003

Yoon, 2013, Advance in photosensitizers and light delivery for photodynamic therapy, Clin. Endosc., 46, 7, 10.5946/ce.2013.46.1.7

Moriwaki, 2018, Synthesis and photophysical properties of S -Mannosylated chlorins and their effect on photocytotoxicity in HeLa cells, Bull. Chem. Soc. Jpn., 91, 230, 10.1246/bcsj.20170271

De Rosa, 2000, Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives, Pharm. Res., 17, 1447, 10.1023/A:1007612905378

Morton, 2002, The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?, J. Dermatol. Treat., 13, s25, 10.1080/095466302317414672

Josefsen, 2008, Photodynamic therapy: novel third-generation photosensitizers one step closer?, Br. J. Pharmacol., 154, 1, 10.1038/bjp.2008.98

Kataoka, 2017, New photodynamic therapy with next-generation photosensitizers, Ann. Transl. Med., 5, 183, 10.21037/atm.2017.03.59

Savellano, 2003, Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates, Photochem. Photobiol., 77, 431, 10.1562/0031-8655(2003)077<0431:TCTOTE>2.0.CO;2

Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat. Rev. Cancer, 17, 20, 10.1038/nrc.2016.108

Ariga, 2011, Layer-by-layer self-assembled shells for drug delivery, Adv. Drug Deliv. Rev., 63, 762, 10.1016/j.addr.2011.03.016

Nakamura, 2017, Significance of optimization of phospholipid poly(Ethylene glycol) quantity for coating carbon nanohorns to achieve low cytotoxicity, Bull. Chem. Soc. Jpn., 90, 662, 10.1246/bcsj.20170003

Hamblin, 2015, Nanotechnology for photodynamic therapy: a perspective from the laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School, Nanotechnol. Rev., 4, 359, 10.1515/ntrev-2015-0027

Lee, 2011, Polymeric nanoparticles for photodynamic therapy, 151, 10.1007/978-1-61779-052-2_11

Hong, 2016, Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials, Acta Pharm. Sin. B, 6, 297, 10.1016/j.apsb.2016.01.007

Hao, 2017, Multifunctional nanoplatform for enhanced photodynamic cancer therapy and magnetic resonance imaging, Colloids Surf. B Biointerfaces, 151, 384, 10.1016/j.colsurfb.2016.10.039

Rong, 2014, Photosensitizer Loaded Nano-Graphene for Multimodality Imaging Guided Tumor Photodynamic Therapy, Theranostics, 4, 229, 10.7150/thno.8070

Ding, 2011, Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxia, J. Control. Release, 156, 276, 10.1016/j.jconrel.2011.08.019

Avci, 2014, Photodynamic therapy: one step ahead with self-assembled nanoparticles, J. Biomed. Nanotechnol., 10, 1937, 10.1166/jbn.2014.1953

Zeisser-Labouèbe, 2006, Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer, Int. J. Pharm., 326, 174, 10.1016/j.ijpharm.2006.07.012

Wang, 2011, Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy, Lasers Surg. Med., 43, 686, 10.1002/lsm.21113

Qin, 2011, Methylene blue covalently loaded polyacrylamide nanoparticles for enhanced tumor-targeted photodynamic therapy, Photochem. Photobiol. Sci., 10, 832, 10.1039/c1pp05022b

Tang, 2008, Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness, Biochem. Biophys. Res. Commun., 369, 579, 10.1016/j.bbrc.2008.02.066

Kuruppuarachchi, 2011, Polyacrylamide nanoparticles as a delivery system in photodynamic therapy, Mol. Pharm., 8, 920, 10.1021/mp200023y

Tang, 2005, Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms, Photochem. Photobiol., 81, 242, 10.1562/2004-05-24-RA-176.1

Kopecek, 2010, HPMA copolymers: origins, early developments, present, and future, Adv. Drug Deliv. Rev., 62, 122, 10.1016/j.addr.2009.10.004

Yang, 2015, Gold nanoparticle-enhanced photodynamic therapy: effects of surface charge and mitochondrial targeting, Ther. Deliv., 6, 307, 10.4155/tde.14.115

Meyers, 2015, Peptide-targeted gold nanoparticles for photodynamic therapy of brain Cancer, Part. Part. Syst. Charact., 32, 448, 10.1002/ppsc.201400119

Xiao, 2011, Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells, ACS Nano, 5, 3651, 10.1021/nn1035262

Komiyama, 2017, Chemistry can make strict and fuzzy controls for bio-systems: DNA nanoarchitectonics and cell-macromolecular nanoarchitectonics, Bull. Chem. Soc. Jpn., 90, 967, 10.1246/bcsj.20170156

Zhang, 2007, Versatile photosensitizers for photodynamic therapy at infrared excitation, J. Am. Chem. Soc., 129, 4526, 10.1021/ja0700707

Choromańska, 2013, Photodynamic therapy – principles, mechanism, clinical applications, Nowa Med., 1, 26

I. Cozzani, G. Jori, G. Bertoloni, C. Milanesi, P. Carlini, T. Sicuro, A. Ruschi, Efficient photosensitization of malignant human cells in vitro by liposome-bound porphyrins., Chem. Biol. Interact. 53 (n.d.) 131–143 http://www.ncbi.nlm.nih.gov/pubmed/3995649.

Konan, 2002, State of the art in the delivery of photosensitizers for photodynamic therapy, J. Photochem. Photobiol. B, 66, 89, 10.1016/S1011-1344(01)00267-6

Paszko, 2011, Nanodrug applications in photodynamic therapy, Photodiagn. Photodyn. Ther., 8, 14, 10.1016/j.pdpdt.2010.12.001

Chen, 2005, Liposomal delivery of photosensitising agents, Expert Opin. Drug Deliv., 2, 477, 10.1517/17425247.2.3.477

Polo, 2002, Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts, Int. J. Biochem. Cell Biol., 34, 10, 10.1016/S1357-2725(01)00092-9

Mazière, 1991, The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours, J. Photochem. Photobiol. B, 8, 351, 10.1016/1011-1344(91)80111-T

Luiza Andreazza, 2016, Int. J. Pharm., 510, 240, 10.1016/j.ijpharm.2016.06.009

Gehl, 2003, Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research, Acta Physiol. Scand., 177, 437, 10.1046/j.1365-201X.2003.01093.x

Potter, 2003, Transfection by electroporation, Curr. Protoc. Mol. Biol.

Reigada, 2014, Electroporation of heterogeneous lipid membranes, Biochim. Biophys. Acta - Biomembr., 1838, 814, 10.1016/j.bbamem.2013.10.008

Cadossi, 2014, Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy, Future Oncol., 10, 877, 10.2217/fon.13.235

Labanauskiene, 2009, Enhancement of photodynamic tumor therapy effectiveness by electroporation in vitro, Med. (Kaunas), 45, 372

Kulbacka, 2011, The influence of electroporation on in vitro photodynamic therapy of human breast carcinoma cells, Folia Biol. (Praha), 57, 112

Kulbacka, 2015, Nanosecond pulsed electric fields (nsPEFs) impact and enhanced Photofrin II® delivery in photodynamic reaction in cancer and normal cells, Photodiagn. Photodyn. Ther., 12, 621, 10.1016/j.pdpdt.2015.11.002

Wezgowiec, 2013, Electric field-assisted delivery of photofrin to human breast carcinoma cells, J. Membr. Biol., 246, 725, 10.1007/s00232-013-9533-z

Choromanska, 2015, Effects of electrophotodynamic therapy in vitro on human melanoma cells – melanotic (MeWo) and amelanotic (C32), Melanoma Res., 25, 210, 10.1097/CMR.0000000000000153

Kulbacka, 2016, Electroporation and lipid nanoparticles with cyanine IR-780 and flavonoids as efficient vectors to enhanced drug delivery in colon cancer, Bioelectrochemistry, 110, 19, 10.1016/j.bioelechem.2016.02.013

Zielichowska, 2015, The photodynamic effect of far-red range phthalocyanines (AlPc and Pc green) supported by electropermeabilization in human gastric adenocarcinoma cells of sensitive and resistant type, Biomed. Pharmacother., 69, 145, 10.1016/j.biopha.2014.11.017

Weżgowiec, 2018, Biological effects in photodynamic treatment combined with electropermeabilization in wild and drug resistant breast cancer cells, Bioelectrochemistry, 123, 9, 10.1016/j.bioelechem.2018.04.008

Wallace, 2009, Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults, Mol. Ther., 17, 922, 10.1038/mt.2009.27